ResMed | RMD - Себестоимость





Себестоимость Изменить Дата
Ansell USD 605.3M 351.2M 2025-12
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 31.94M 3.22M 2026-03
Baxter International USD 1.81B 587M 2026-03
Cochlear AUD 319.2M 160.35M 2025-12
Cooper Companies USD 393.8M 17M 2026-03
CSL USD 3.87B 2.08B 2025-12
Dexcom USD 441.6M 25.3M 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Fisher Paykel Healthcare NZD 402.8M 15.2M 2025-12
Globus Medical USD 263.59M 26.88M 2026-03
Haemonetics USD 136.58M 4.01M 2025-12
Idexx Laboratories USD 418.08M 14.38M 2026-03
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 232.7M 17.5M 2026-03
Integra LifeSciences USD 178.71M 14.73M 2026-03
Intuitive Surgical USD 940.3M 21.6M 2026-03
Masimo USD 152.8M 12.4M 2026-03
Medtronic USD 3.8B 195M 2026-03
Philips EUR 2.14B 669M 2026-03
Ramsay Health Care AUD 3.05B 78.7M 2025-12
ResMed USD 551.67M 4.17M 2026-03
Sigma Healthcare AUD 1.55B 165.16M 2024-12
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Steris USD 891.3M 50.6M 2026-03
Teleflex USD 240.84M 20.7M 2026-03
Thermo Fisher Scientific USD 6.96B 620M 2026-03